Universal Vision Biotechnology Co., Ltd.
TWO: 3218.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Zhenghong Lu
- Employees
- 401
- Headquarters
- Taipei, Taiwan
- IPO year
- 2007
- Market cap
- NT$11.2B
- Website
- https://www.uvb.com.tw
Loading 3218…
Loading profile data…Frequently asked questions about 3218
What does Universal Vision Biotechnology Co., Ltd. (3218.TWO) do?
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. Its clinic provides laser vision correction surgery for myopia, hyperopia, astigmatism, and presbyopia; intraocular lens surgery for presbyopia and cataract; phacoemulsification and femtosecond laser for cataract surgery; and myopia control service...
Where does 3218.TWO trade?
Universal Vision Biotechnology Co., Ltd. (3218.TWO) trades on the Taipei Exchange.
What sector is 3218.TWO in?
Universal Vision Biotechnology Co., Ltd. (3218.TWO) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Universal Vision Biotechnology Co., Ltd.?
Zhenghong Lu is the chief executive officer of Universal Vision Biotechnology Co., Ltd. (3218.TWO).
Where is Universal Vision Biotechnology Co., Ltd. headquartered?
Universal Vision Biotechnology Co., Ltd. is headquartered in Taiwan.
Does 3218.TWO pay a dividend?
Yes — Universal Vision Biotechnology Co., Ltd. (3218.TWO) paid a trailing twelve-month dividend of TWD 7.75 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 3218.TWO go public?
Universal Vision Biotechnology Co., Ltd. (3218.TWO) completed its initial public offering in 2007.